These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9593128

  • 1. Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model.
    Brun-Pascaud M, Rajagopalan-Levasseur P, Chau F, Bertrand G, Garry L, Derouin F, Girard PM.
    Antimicrob Agents Chemother; 1998 May; 42(5):1068-72. PubMed ID: 9593128
    [Abstract] [Full Text] [Related]

  • 2. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
    Brun-Pascaud M, Chau F, Derouin F, Girard PM.
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
    [Abstract] [Full Text] [Related]

  • 3. Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
    Brun-Pascaud M, Chau F, Garry L, Jacobus D, Derouin F, Girard PM.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2067-70. PubMed ID: 8878582
    [Abstract] [Full Text] [Related]

  • 4. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M, Chau F, Simonpoli AM, Girard PM, Derouin F, Pocidalo JJ.
    J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
    [Abstract] [Full Text] [Related]

  • 5. A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
    Mehlhorn H, Dankert W, Hartman PG, Then RL.
    Parasitol Res; 1995 Sep; 81(4):296-301. PubMed ID: 7624286
    [Abstract] [Full Text] [Related]

  • 6. Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model.
    Brun-Pascaud M, Chau F, Garry L, Farinotti R, Derouin F, Girard PM.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov 01; 13(3):201-7. PubMed ID: 8898664
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the activities of rifabutin combined with atovaquone or low-dose of cotrimoxazole for prevention of pneumocystosis and toxoplasmosis in a dual infection rat model.
    Brun-Pascaud M, Chau F, Rajagopalan-Levasseur P, Derouin F, Girard PM.
    J Eukaryot Microbiol; 1996 Nov 01; 43(5):14S-15S. PubMed ID: 8822822
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients.
    Durant J, Hazime F, Carles M, Pechere JC, Dellamonica P.
    Infection; 1995 Nov 01; 23 Suppl 1():S33-8. PubMed ID: 7782114
    [Abstract] [Full Text] [Related]

  • 9. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR, Johnson CA, Krauth CA, Carter RL, Hosmer CA, Queener SF, Borotz SE, Pfefferkorn ER.
    J Med Chem; 1996 Mar 15; 39(6):1271-80. PubMed ID: 8632434
    [Abstract] [Full Text] [Related]

  • 10. Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies.
    Walzer PD, Runck J, Orr S, Foy J, Steele P, White M.
    Antimicrob Agents Chemother; 1997 Feb 15; 41(2):242-50. PubMed ID: 9021174
    [Abstract] [Full Text] [Related]

  • 11. Pneumocystis carinii and Mycobacterium avium-intracellulare infection of the choroid.
    Whitcup SM, Fenton RM, Pluda JM, De Smet MD, Nussenblatt RB, Chan CC.
    Retina; 1992 Feb 15; 12(4):331-5. PubMed ID: 1485017
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC, Fu H, Forsch RA, Queener SF, Rosowsky A.
    J Med Chem; 2005 Jun 30; 48(13):4420-31. PubMed ID: 15974594
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC, Griffith L, Guyatt GH, Opravil M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun 01; 15(2):104-14. PubMed ID: 9241108
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A, Forsch RA, Queener SF.
    J Med Chem; 2002 Jan 03; 45(1):233-41. PubMed ID: 11754594
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A, Papoulis AT, Forsch RA, Queener SF.
    J Med Chem; 1999 Mar 25; 42(6):1007-17. PubMed ID: 10090784
    [Abstract] [Full Text] [Related]

  • 16. Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents.
    Kovacs JA, Allegra CJ, Beaver J, Boarman D, Lewis M, Parrillo JE, Chabner B, Masur H.
    J Infect Dis; 1989 Aug 25; 160(2):312-20. PubMed ID: 2527275
    [Abstract] [Full Text] [Related]

  • 17. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
    Alder J, Hutch T, Meulbroek JA, Clement JC.
    J Acquir Immune Defic Syndr (1988); 1994 Nov 25; 7(11):1141-8. PubMed ID: 7932081
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HIV: opportunistic infections.
    Ioannidis J, Wilkinson D.
    Clin Evid; 2003 Jun 25; (9):795-816. PubMed ID: 15366175
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.